2012
DOI: 10.4172/2161-1009.1000123
|View full text |Cite
|
Sign up to set email alerts
|

In Silico Identification of Common Putative Drug Targets among the Pathogens of Bacterial Meningitis

Abstract: Monitoring infectious emerging diseases, especially the central nervous system infections, has become one of the important priorities in health care system. Epidemiological, serological and bacteriological studies revealed that Streptococcus pneumonia, Neisseria meningitidis, Haemophilus influenzae type b and Staphylococcus aureus are common pathogens of bacterial meningitis. Therefore, identification of common drug targets in these pathogens would be crucial to overcome drug resistance to existing antibiotic … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
6
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 59 publications
1
6
0
Order By: Relevance
“…Five unique pathways of M. globosa are carbapenem biosynthesis, various types of N-glycon biosynthesis, C-5 branched dibasic acid metabolisms, methane metabolism, sesquiterpenoid and triterpenoid biosynthesis. In this study, unique pathways have 29 enzymes of which 28 enzymes are involved in common pathways which is in accordance with the report [40] which stated that common drug targets are also involved in the pathway unique to the pathogens of bacterial meningitis. Also, the number of drug targets identified from the common pathways of M. globosa were more than that identified among Streptococcus pneumonia, Neisseria meningitidis, Haemophilus influenzae type b and Staphylococcus aureus causing bacterial meningitis.…”
Section: Common and Unique Targetssupporting
confidence: 89%
“…Five unique pathways of M. globosa are carbapenem biosynthesis, various types of N-glycon biosynthesis, C-5 branched dibasic acid metabolisms, methane metabolism, sesquiterpenoid and triterpenoid biosynthesis. In this study, unique pathways have 29 enzymes of which 28 enzymes are involved in common pathways which is in accordance with the report [40] which stated that common drug targets are also involved in the pathway unique to the pathogens of bacterial meningitis. Also, the number of drug targets identified from the common pathways of M. globosa were more than that identified among Streptococcus pneumonia, Neisseria meningitidis, Haemophilus influenzae type b and Staphylococcus aureus causing bacterial meningitis.…”
Section: Common and Unique Targetssupporting
confidence: 89%
“…In addition, elevated inositol phosphate metabolism has been observed with Pneumocystis pneumonia [ 34 ] and S. aureus infection in type II alveolar epithelial cells [ 35 ]. Methane metabolism pathways have been shown to be elevated in bacterial meningitis caused by pathogenesis of different species, such as S. pneumoniae , N. meningitis , Haemophilus influenzae , and S. aureus [ 36 ].…”
Section: Discussionmentioning
confidence: 99%
“…It catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. Substrate specificity of fabH determines the biosynthesis of branched-chain and/or straightchain of fatty acids [45]. FabH catalyses two stages such as acetyl Co-A condensation and malonyl-ACP decarboxylase reaction, blocking the ping-pong reaction of fabH will prevent the fatty acid biosynthesis.…”
Section: Enzymes As Drug Targetsmentioning
confidence: 99%
“…FabH catalyses two stages such as acetyl Co-A condensation and malonyl-ACP decarboxylase reaction, blocking the ping-pong reaction of fabH will prevent the fatty acid biosynthesis. The enzyme is also reported as potential drug target against Streptococcus pneumonia, Neisseria meningitides, Haemophilys influnzae, Staphylococcus aureus, Enterococcus faecalis, Streptococcus mitis, Bortonella quintana, Coxiella burnetti, Legionella pneumopholi, Brucella melitensis and Biovar abartus [13,45].…”
Section: Enzymes As Drug Targetsmentioning
confidence: 99%